• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Other News

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

China NMPA Approves Tigertriever Revascularization Device For Market

2023-09-27

On August 17, 2023, NMPA approved for the registration application of the Tigertriever Revascularization Device manufactured by Rapid…

NMPA New Approvals In August 2023

2023-09-19

In August 2023, NMPA approved 288 medical devices, including 33 Class III imported products, 24 Class II imported…

NMPA Updated Medical Device Classification Catalog (No. 101 Of 2023)

2023-09-10

In accordance with the relevant requirements of the Regulations for the Supervision and Administration of Medical Devices (Order…

China NMPA Newsletter – July 2023

2023-08-31

Featured Articles NMPA New Approvals in July 2023 In July 2023, NMPA approved 197 medical devices, including 21 Class III…

China NMPA Releases The Results Of Medical Device Sampling Inspections

2023-08-30

In order to strengthen the supervision and management of medical devices, and ensure that the quality of medical…

NMPA New Approvals In July 2023

2023-08-29

In July 2023, NMPA approved 197 medical devices, including 21 Class III imported products, 21 Class II imported…

China Clinical Trial Inspection Result Release For 12 Projects

2023-08-14

As per the "Regulations for the Supervision and Administration of Medical Devices" (Order 739) effective since 2021 and…

China NMPA Newsletter – June 2023

2023-08-02

Featured Articles NMPA New Approvals in June 2023 In June 2023, NMPA approved 264 medical devices, including 46…

NMPA Updated The Medical Device Clinical Evaluation Exempt Catalogue

2023-08-01

On July 20, NMPA released the updated "Medical Device Clinical Evaluation Exempt Catalogue" (NMPA, No. 71, 2021) in…

NMPA New Approvals In June 2023

2023-07-24

In June 2023, NMPA approved 264 medical devices, including 46 Class III imported products, 19 Class II imported…

NMPA Enhanced Medical Device Classification Management

2023-07-20

On July 19, NMPA issued a notice on further strengthening and improving the classification management of medical devices.…

Summary Of China Standards Of 9706 Series Effective Since May 1, 2023

2023-07-19

China standards of 9706 series have been effective since May 1, 2023. The summary is shown as below.…
« Prev...34567...101214...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7